These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35324976)
21. Effect of statins on the treatment of early diabetic nephropathy: a systematic review and meta-analysis of nine randomized controlled trials. Lv J; Ren C; Hu Q Ann Palliat Med; 2021 Nov; 10(11):11548-11557. PubMed ID: 34872280 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: systematic review and meta-analysis. Pelliccia F; Patti G; Rosano G; Greco C; Gaudio C Int J Cardiol; 2014 Nov; 177(1):219-28. PubMed ID: 25499383 [TBL] [Abstract][Full Text] [Related]
23. Effects of Alpha-lipoic Acid Supplementation on Human Diabetic Nephropathy: A Systematic Review and Meta-analysis. Vakali E; Rigopoulos D; Carrillo AE; Flouris AD; Dinas PC Curr Diabetes Rev; 2022; 18(6):e140921196457. PubMed ID: 34521329 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of Bailing capsules in the treatment of type 2 diabetic nephropathy: a meta-analysis. Sheng X; Dong Y; Cheng D; Wang N; Guo Y Ann Palliat Med; 2020 Nov; 9(6):3885-3898. PubMed ID: 33222468 [TBL] [Abstract][Full Text] [Related]
25. Long-term effect of eplerenone treatment in children with chronic allograft nephropathy. Baskin E; Siddiqui MA; Gülleroğlu K; Özdemir BH; Yılmaz AÇ; Çolak MY; Akdur A; Soy EA; Moray G; Haberal M Pediatr Transplant; 2023 Sep; 27(6):e14557. PubMed ID: 37283242 [TBL] [Abstract][Full Text] [Related]
26. Meta-analysis-based systematic review of effect of traditional Chinese medicine intervention in treatment of diabetic nephropathy on thyroid function. Zhang X; Wu M; Zhou J; Zhou R; Luo Q; Yue R; Jin S Ann Palliat Med; 2021 Jun; 10(6):6736-6752. PubMed ID: 34154352 [TBL] [Abstract][Full Text] [Related]
27. Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy. Sun LJ; Sun YN; Shan JP; Jiang GR J Diabetes Investig; 2017 Jul; 8(4):609-618. PubMed ID: 28107779 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of mineralocorticoid receptor antagonists with ACEI/ARB treatment for diabetic nephropathy: A meta-analysis. Zuo C; Xu G Int J Clin Pract; 2019 Aug; ():e13413. PubMed ID: 31464019 [TBL] [Abstract][Full Text] [Related]
29. Clinical Efficacy and Safety of Jinshuibao Combined With ACEI/ARB in the Treatment of Diabetic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials. Li Y; Xu G J Ren Nutr; 2020 Mar; 30(2):92-100. PubMed ID: 31201013 [TBL] [Abstract][Full Text] [Related]
30. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial. Bakris GL; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Kolkhof P; Joseph A; Pieper A; Kimmeskamp-Kirschbaum N; Ruilope LM; JAMA; 2015 Sep; 314(9):884-94. PubMed ID: 26325557 [TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of the efficacy of liraglutide in patients with type 2 diabetes accompanied by incipient nephropathy. Liu W; Yu J; Tian T; Miao J; Shang W Exp Ther Med; 2019 Jul; 18(1):342-351. PubMed ID: 31258671 [TBL] [Abstract][Full Text] [Related]
32. Effect of Vitamin D on Urinary Albumin Excretion in Diabetic Nephropathy Patients: A Meta-analysis of Randomized Controlled Trials. He L; Zhou L; Zhao TY; Witherspoon AT; Ouyang L Iran J Kidney Dis; 2022 Sep; 16(5):273-279. PubMed ID: 36178860 [TBL] [Abstract][Full Text] [Related]
33. Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease. Wu Y; Lin H; Tao Y; Xu Y; Chen J; Jia Y; Zheng Z Front Pharmacol; 2022; 13():967317. PubMed ID: 36188560 [TBL] [Abstract][Full Text] [Related]
34. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review. Mavrakanas TA; Gariani K; Martin PY Eur J Intern Med; 2014 Feb; 25(2):173-6. PubMed ID: 24315413 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic Efficacy of Piperazine Ferulate Combined With Irbesartan in Diabetic Nephropathy: A Systematic Review and Meta-analysis. Li D; Li B; Peng LX; Liu R; Zeng N Clin Ther; 2020 Nov; 42(11):2196-2212. PubMed ID: 33158581 [TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials. Yang P; Shen W; Chen X; Zhu D; Xu X; Wu T; Xu G; Wu Q Heart Fail Rev; 2019 Sep; 24(5):637-646. PubMed ID: 31030322 [TBL] [Abstract][Full Text] [Related]
37. Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: a meta-analysis. Yang G; Zhang M; Zhang M; Chen S; Chen P J Tradit Chin Med; 2015 Feb; 35(1):15-20. PubMed ID: 25842723 [TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E1 for preventing the progression of diabetic kidney disease. Wang H; Deng JL; Yue J; Li J; Hou YB Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745 [TBL] [Abstract][Full Text] [Related]
39. Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis. Sun F; Jiang D; Cai J BMC Endocr Disord; 2021 Aug; 21(1):178. PubMed ID: 34465338 [TBL] [Abstract][Full Text] [Related]
40. Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy. Ren F; Tang L; Cai Y; Yuan X; Huang W; Luo L; Zhou J; Zheng Y Ren Fail; 2015 May; 37(4):548-61. PubMed ID: 25707526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]